-
1
-
-
70349563344
-
Advances in diagnosis, treatment and palliation of cholangiocarcinoma: 1990-2009
-
M. Aljiffry, M.J. Walsh, and M. Molinari Advances in diagnosis, treatment and palliation of cholangiocarcinoma: 1990-2009 World J Gastroenterol 15 2009 34 Review
-
(2009)
World J Gastroenterol
, vol.15
, pp. 34
-
-
Aljiffry, M.1
Walsh, M.J.2
Molinari, M.3
-
2
-
-
0034982536
-
Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States
-
T. Patel Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States Hepatology 33 2001 6
-
(2001)
Hepatology
, vol.33
, pp. 6
-
-
Patel, T.1
-
3
-
-
35148831187
-
Triptolide induces pancreatic cancer cell death via inhibition of heat shock protein 70
-
P.A. Phillips, V. Dudeja, and J.A. McCarroll Triptolide induces pancreatic cancer cell death via inhibition of heat shock protein 70 Cancer Res 67 2007 19
-
(2007)
Cancer Res
, vol.67
, pp. 19
-
-
Phillips, P.A.1
Dudeja, V.2
McCarroll, J.A.3
-
4
-
-
67650552674
-
Triptolide therapy for neuroblastoma decreases cell viability in vitro and inhibits tumor growth in vivo
-
M.B. Antonoff, R. Chugh, and D. Borja-Cacho Triptolide therapy for neuroblastoma decreases cell viability in vitro and inhibits tumor growth in vivo Surgery 146 2009 2
-
(2009)
Surgery
, vol.146
, pp. 2
-
-
Antonoff, M.B.1
Chugh, R.2
Borja-Cacho, D.3
-
5
-
-
77956932818
-
TRAIL and triptolide: An effective combination that induces apoptosis in pancreatic cancer cells
-
D. Borja-Cacho, Y. Yokoyama, and R.K. Chugh TRAIL and triptolide: An effective combination that induces apoptosis in pancreatic cancer cells J Gastrointest Surg 2009 (in press)
-
(2009)
J Gastrointest Surg
-
-
Borja-Cacho, D.1
Yokoyama, Y.2
Chugh, R.K.3
-
6
-
-
13344285339
-
Identification and characterization of a new member of the TNF family that induces apoptosis
-
S.R. Wiley, K. Schooley, and P.J. Smolak Identification and characterization of a new member of the TNF family that induces apoptosis Immunity 3 1995 6
-
(1995)
Immunity
, vol.3
, pp. 6
-
-
Wiley, S.R.1
Schooley, K.2
Smolak, P.J.3
-
7
-
-
0032713075
-
Safety and antitumor activity of recombinant soluble Apo2 ligand
-
A. Ashkenazi, R.C. Pai, and S. Fong Safety and antitumor activity of recombinant soluble Apo2 ligand J Clin Invest 104 1999 2
-
(1999)
J Clin Invest
, vol.104
, pp. 2
-
-
Ashkenazi, A.1
Pai, R.C.2
Fong, S.3
-
8
-
-
0033083990
-
Chemotherapy augments TRAIL-induced apoptosis in breast cell lines
-
M.M. Keane, S.A. Ettenberg, and M.M. Nau Chemotherapy augments TRAIL-induced apoptosis in breast cell lines Cancer Res 59 1999 3
-
(1999)
Cancer Res
, vol.59
, pp. 3
-
-
Keane, M.M.1
Ettenberg, S.A.2
Nau, M.M.3
-
9
-
-
0032929520
-
Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo
-
H. Walczak, R.E. Miller, and K. Ariail Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo Nat Med 5 1999 2
-
(1999)
Nat Med
, vol.5
, pp. 2
-
-
Walczak, H.1
Miller, R.E.2
Ariail, K.3
-
10
-
-
0032883420
-
Synergistic cytotoxicity and apoptosis by Apo-2 ligand and adriamycin against bladder cancer cells
-
Y. Mizutani, O. Yoshida, and T. Miki Synergistic cytotoxicity and apoptosis by Apo-2 ligand and adriamycin against bladder cancer cells Clin Cancer Res 5 1999 9
-
(1999)
Clin Cancer Res
, vol.5
, pp. 9
-
-
Mizutani, Y.1
Yoshida, O.2
Miki, T.3
-
11
-
-
33646236326
-
Crosstalk between extrinsic and intrinsic cell death pathways in pancreatic cancer: Synergistic action of estrogen metabolite and ligands of death receptor family
-
A. Basu, V.P. Castle, and M. Bouziane Crosstalk between extrinsic and intrinsic cell death pathways in pancreatic cancer: Synergistic action of estrogen metabolite and ligands of death receptor family Cancer Res 66 2006 8
-
(2006)
Cancer Res
, vol.66
, pp. 8
-
-
Basu, A.1
Castle, V.P.2
Bouziane, M.3
-
12
-
-
0041333929
-
PG490-mediated sensitization of lung cancer cells to Apo2L/TRAIL-induced apoptosis requires activation of ERK2
-
S. Frese, F. Pirnia, and D. Miescher PG490-mediated sensitization of lung cancer cells to Apo2L/TRAIL-induced apoptosis requires activation of ERK2 Oncogene 22 2003 35
-
(2003)
Oncogene
, vol.22
, pp. 35
-
-
Frese, S.1
Pirnia, F.2
Miescher, D.3
-
13
-
-
43549107334
-
Triptolide sensitizes AML cells to TRAIL-induced apoptosis via decrease of XIAP and p53-mediated increase of DR5
-
B.Z. Carter, D.H. Mak, and W.D. Schober Triptolide sensitizes AML cells to TRAIL-induced apoptosis via decrease of XIAP and p53-mediated increase of DR5 Blood 111 2008 7
-
(2008)
Blood
, vol.111
, pp. 7
-
-
Carter, B.Z.1
Mak, D.H.2
Schober, W.D.3
-
14
-
-
32144455416
-
Triptolide sensitizes resistant cholangiocarcinoma cells to TRAIL-induced apoptosis
-
T. Panichakul, P. Intachote, and A. Wongkajorsilp Triptolide sensitizes resistant cholangiocarcinoma cells to TRAIL-induced apoptosis Anticancer Res 26 2006 1A
-
(2006)
Anticancer Res
, vol.26
-
-
Panichakul, T.1
Intachote, P.2
Wongkajorsilp, A.3
-
15
-
-
0035831473
-
Executioner caspase-3, -6, and -7 perform distinct, non-redundant roles during the demolition phase of apoptosis
-
E.A. Slee, C. Adrain, and S.J. Martin Executioner caspase-3, -6, and -7 perform distinct, non-redundant roles during the demolition phase of apoptosis J Biol Chem 276 2001 10
-
(2001)
J Biol Chem
, vol.276
, pp. 10
-
-
Slee, E.A.1
Adrain, C.2
Martin, S.J.3
-
16
-
-
0030810926
-
X-linked IAP is a direct inhibitor of cell-death proteases
-
Q.L. Deveraux, R. Takahashi, and G.S. Salvesen X-linked IAP is a direct inhibitor of cell-death proteases Nature 388 1997 6639
-
(1997)
Nature
, vol.388
, pp. 6639
-
-
Deveraux, Q.L.1
Takahashi, R.2
Salvesen, G.S.3
|